Anticancer Effects of Emodin on HepG2 Cell: Evidence from Bioinformatic Analysis

Hepatocellular carcinoma (HCC) is a primary cause of cancer-related death in the world. Despite the fact that there are many methods to treat HCC, the 5-year survival rate of HCC is still at a low level. Emodin can inhibit the growth of HCC cells in vitro and in vivo. However, the gene regulation of...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:Biomed Res Int
Autori principali: Zhou, Rui-sheng, Wang, Xiong-Wen, Sun, Qin-feng, Ye, Zeng Jie, Liu, Jian-wei, Zhou, Dai-Han, Tang, Ying
Natura: Artigo
Lingua:Inglês
Pubblicazione: Hindawi 2019
Soggetti:
Research Article
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC6545785/
https://ncbi.nlm.nih.gov/pubmed/31236404
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1155/2019/3065818
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi